The Clinical Efficacy of Dilatation and Evacuation Therapy for Cesarean Scar Pregnancy

To evaluate the therapeutic efficacy of dilatation and evacuation (D&E) for cesarean scar pregnancy (CSP) and to determine prognostic factors. Methods This study was retrospectively performed in 68 women who had been diagnosed with CSP. The 56 CSP women were enrolled for whom D&E was the primary treatment. The patients were divided into two groups according to treatment outcomes. Women who received D&E only were defined as the success group and patients who required additional treatment were categorized as the failure group. Demographic, clinical, and sonographic characteristics according to treatment results were analyzed. Results Among the total of 56, 36 (64%) women were treated by D&E only, and 20 (36%) women underwent additional treatments. There were no significant difference in maternal age, gravida, number of previous cesarean section, initial symptoms, but significant difference in parity (≥2), gestational age at diagnosis, serum ß-human chorionic gonadotropin level, postoperative stay, and time to resolution was present ( P